Animal pathological section examination is a core laboratory technique that evaluates disease-related morphological changes in animal tissues at the microscopic level, supporting preclinical safety studies, biocompatibility testing, and veterinary diagnosis. By combining professional tissue processing, staining, and expert pathological interpretation, this method provides the definitive morphological evidence required for regulatory submissions and research conclusions. This guide explains the sample types, testing items, methods, applications, and frequently asked questions related to animal histopathology testing performed by accredited third-party laboratories.
Technical Overview
Animal pathological section examination, also known as veterinary histopathology, is the systematic preparation and microscopic evaluation of stained tissue sections derived from animal organs, lesions, tumors, or implantation sites. The technique converts biological tissue into ultra-thin sections typically 3 to 5 micrometers thick, which are mounted on glass slides, stained, and examined by qualified veterinary pathologists to identify structural abnormalities such as inflammation, degeneration, necrosis, hyperplasia, fibrosis, and neoplasia.
The complete workflow encompasses necropsy sampling, chemical fixation, dehydration, clearing, paraffin embedding, microtomy, staining, microscopic diagnosis, and structured reporting. Histopathology is widely regarded as the gold standard for morphological diagnosis because it preserves the in situ relationship between cells and their surrounding tissue architecture, which cannot be achieved by biochemical assays or imaging alone.
In a regulated context, animal pathological section examination is performed under Good Laboratory Practice (GLP) principles and aligned with recognized standards frameworks such as the ISO 10993 series for the biological evaluation of medical devices (notably ISO 10993-6 for local effects after implantation and ISO 10993-11 for systemic toxicity), the corresponding GB/T 16886 national standard series, and relevant ASTM practices such as ASTM F981 and ASTM F748 for biological response testing of materials and devices. Accredited third-party laboratories routinely apply these frameworks to ensure that study data are traceable, reproducible, and acceptable to regulatory reviewers.
Testing Samples
Visceral Organs
Routine toxicity studies typically submit a comprehensive panel of organs including liver, kidney, heart, lung, spleen, brain, stomach, intestine, pancreas, adrenal, thyroid, thymus, lymph nodes, urinary bladder, reproductive organs, and bone marrow with femur or sternum. Each organ is trimmed to a standardized maximum thickness of approximately 5 millimeters to guarantee uniform penetration of fixative and consistent section quality.
Tumor and Lesion Tissues
Spontaneous or induced masses, nodules, ulcers, and suspicious lesions from animal models or veterinary clinical cases are sampled together with adjacent normal tissue. Including the tumor-normal boundary allows the pathologist to evaluate invasiveness, margins, and the transition zone between healthy and diseased tissue.
Skin and Subcutaneous Tissue
Skin biopsies from irritation, sensitization, photo-toxicity, and wound-healing studies require careful orientation so that sections are cut perpendicular to the epidermal surface. Correct orientation is essential for measuring epidermal thickness, evaluating inflammatory infiltrates, and scoring dermal reactions according to standardized severity scales.
Implantation Sites
For medical device and biomaterial biocompatibility studies following ISO 10993-6, implant sites from muscle, bone, or subcutaneous locations are harvested with surrounding tissue, fixed, and in the case of bone-adjacent specimens, decalcified before sectioning. The tissue-biomaterial interface is the critical region evaluated for fibrous capsule formation, inflammation, and degenerative changes.
Hard Tissue and Calcified Specimens
Bone, teeth, and calcified lesions undergo controlled decalcification using acid or chelating agents such as EDTA after adequate fixation. For evaluations that must preserve mineralized architecture, such as osteointegration studies, undecalcified resin embedding and ground or thin sectioning techniques are available.
Nervous System Tissues
Brain, spinal cord, peripheral nerves, and ganglia require perfusion fixation or immersion fixation with careful handling to avoid artifacts. Special orientation and sectioning planes, including coronal brain levels and transverse nerve sections, are applied for neurotoxicity assessment.
Developmental and Reproductive Specimens
Embryos, fetuses, placentas, and reproductive tracts from developmental and reproductive toxicity studies are processed with specialized techniques, including decalcification of fetal skeletons, razor blade sectioning of fetuses, or paraffin embedding after fixation in Davidson's solution for optimal fetal tissue morphology.
Testing Items
Animal pathological section examination covers a tiered portfolio of analytical services, progressing from routine morphological screening to targeted molecular characterization.
- Routine hematoxylin and eosin (H&E) staining for general morphology and primary diagnosis of tissue lesions
- Special staining panels including Masson's trichrome and Sirius Red for collagen and fibrosis, PAS and Alcian Blue for glycogen, basement membranes, and mucins, Oil Red O for lipids on frozen sections, Congo Red for amyloid, Prussian Blue for hemosiderin iron, Von Kossa for calcium deposits, and Verhoeff-Van Gieson for elastic fibers
- Microbial-related staining such as Gram, Ziehl-Neelsen acid-fast, Giemsa, and Grocott methenamine silver for bacteria, mycobacteria, mast cells, and fungi
- Immunohistochemistry (IHC) using validated antibodies against markers such as Ki-67, CD3, CD79a, CD68, F4/80, Iba1, GFAP, cytokeratin, CD31, alpha-SMA, and cleaved caspase-3 for cell identification, proliferation, apoptosis, and phenotyping
- Immunofluorescence and multiplex immunofluorescence for co-localization analysis of multiple targets within a single section
- In situ hybridization (ISH) and RNA-ISH for the tissue-localized detection of nucleic acid sequences, viral genomes, and gene expression
- TUNEL and cleaved caspase-3 assays for apoptotic cell quantification
- Semi-quantitative pathological scoring and morphometric measurement, including lesion severity grading, implant site biological response scoring consistent with ISO 10993-6 criteria, and stereological quantification
- Digital whole-slide scanning and computer-assisted image analysis for objective, reproducible quantification of positive areas, cell counts, and fiber dimensions
- Expert pathological diagnosis, peer review, and pathology working group consultation for complex or regulatory-critical findings
Testing Methods
The examination follows a rigorously controlled laboratory workflow designed to preserve tissue morphology and ensure diagnostic reproducibility.
1. Sampling and Fixation
Representative tissue blocks are collected promptly during necropsy or biopsy, with a maximum thickness of about 5 millimeters. Specimens are immersed in at least ten times their volume of 10% neutral buffered formalin for 24 to 72 hours. Alternative fixatives such as Davidson's solution for eyes and testes, Bouin's solution for select soft tissues, or paraformaldehyde for molecular downstream assays may be applied when indicated. Proper labeling and chain-of-custody documentation are maintained throughout.
2. Trimming and Gross Description
Fixed specimens are trimmed to standardized anatomic planes, described macroscopically, and cassetteed. Consistent trimming guides are used so that comparable anatomic regions are evaluated across animals and studies, which is fundamental for valid between-group comparison.
3. Dehydration, Clearing, and Embedding
Tissues are passed through graded alcohols, cleared in xylene or safer substitutes, and infiltrated with molten paraffin using automated tissue processors. Specimens are then oriented deliberately in molds and embedded into paraffin blocks, with orientation verified to guarantee that diagnostic regions appear on the section.
4. Sectioning
Paraffin blocks are cut on rotary microtomes at 3 to 5 micrometers, and sections are floated in a water bath, mounted on positively charged glass slides, and dried. Frozen specimens, when rapid diagnosis or lipid and enzyme preservation is required, are sectioned at 5 to 10 micrometers in a cryostat. Serial and step sections are prepared for three-dimensional lesion reconstruction or IHC panels when needed.
5. Staining
Routine slides are stained with hematoxylin and eosin, dehydrated, cleared, and coverslipped. Special stains and immunohistochemistry are performed on charged slides using validated protocols with appropriate positive and negative controls, antigen retrieval where required, and chromogenic or fluorescent detection systems.
6. Microscopic Examination and Reporting
Board-qualified veterinary pathologists examine slides using brightfield or fluorescence microscopy, describe findings using standardized nomenclature, assign severity grades, and correlate results with study design, clinical observations, and laboratory data. Reports include gross and microscopic descriptions, diagnosis, lesion distribution tables across dose groups, photomicrographs, and a scientific conclusion. Peer review by a second pathologist is available for GLP and regulatory studies.
Applications
Animal pathological section examination serves as a decisive endpoint across pharmaceutical, biotechnology, medical device, veterinary, and academic research fields.
- Preclinical drug safety and toxicology: histopathological evaluation of rodent and non-rodent studies to identify target organ toxicity, dose-response relationships, and reversibility of findings
- Medical device biocompatibility: local tissue response assessment of implants, scaffolds, and materials following ISO 10993-6 and the GB/T 16886 series, including irritant and systemic response characterization aligned with ISO 10993-11 and ISO 10993-23
- Veterinary clinical diagnosis: morphological diagnosis of biopsy and necropsy specimens from companion, livestock, laboratory, and exotic animals, including tumor classification and grading
- Animal model validation and phenotyping: confirmation of genetically engineered or chemically induced disease models, efficacy evaluation of drug candidates, and longitudinal disease progression studies
- Regenerative medicine and biomaterials: evaluation of degradation behavior, osteointegration, vascularization, and host response of tissue-engineered products and novel biomaterials in line with ASTM testing practices
- Food and feed safety: identification of pathological lesions in food-producing animals and assessment of potential residues or contaminant-related tissue injury
- Environmental and ecotoxicology: histopathological biomarkers in fish, aquatic organisms, and wildlife for environmental exposure assessment
- Basic research support: morphological evidence for mechanism-of-action studies, gene function research, and publication-quality pathology data with digital imaging
FAQ
How should tissue samples be collected and submitted?
Samples should be collected as soon as possible after death or biopsy, cut to no more than 5 millimeters thick, and immediately immersed in 10% neutral buffered formalin at a fixative-to-tissue volume ratio of at least 10 to 1. Each container must be clearly labeled with the animal identification, organ, and collection date. Accompanying information such as study protocol, animal strain, sex, age, treatment group, and clinical history enables accurate interpretation.
How long can specimens remain in formalin before processing?
Most tissues are adequately fixed within 24 to 72 hours. Prolonged storage in formalin for weeks or months may cause antigen loss and compromise immunohistochemistry performance; in such cases, antigen retrieval optimization or transfer to 70% ethanol after fixation may be recommended by the laboratory.
What is the difference between paraffin and frozen sections?
Paraffin sections provide the best morphological detail and are the standard for routine diagnosis and archiving, whereas frozen sections offer rapid turnaround within minutes to hours and better preserve lipids, enzymes, and heat-sensitive antigens. Frozen sections are preferred for urgent intraoperative-style decisions, fat staining with Oil Red O, and certain fluorescence applications.
Can hard tissues such as bone be examined?
Yes. Calcified tissues are fixed first and then decalcified using acid-based or EDTA-based methods before routine processing. When mineralized structure must be preserved, undecalcified embedding in resin with specialized sectioning is performed, which is common in bone implant and osteointegration studies.
What is the typical turnaround time?
Standard H&E histopathology for routine specimens is generally completed within five to ten working days after sample receipt, while large organ panels, decalcified specimens, special stains, immunohistochemistry, and digital image analysis require additional time. Urgent projects can often be expedited under agreed priority arrangements with the laboratory.
What deliverables are provided?
Final deliverables typically include stained slides, paraffin blocks, digital whole-slide images when requested, a formal pathology report with gross and microscopic descriptions, standardized diagnosis terminology, severity grading, group comparison tables, representative photomicrographs, and a conclusion signed by the responsible veterinary pathologist. All raw data and specimens are archived according to GLP retention requirements where applicable.
Is quantitative analysis available?
Yes. Semi-quantitative severity scoring, morphometric measurement, stereology, positive-cell or positive-area quantification, and AI-assisted digital image analysis can be provided, delivering objective numerical endpoints suitable for statistical analysis and regulatory submission.